Box score
GelMEDIX, Inc.
Reported $1.9M sold in a new Form D filed March 26, 2024 (Cambridge, Massachusetts).
- Biggest raise
- $1.9M filed Mar 26, 2024
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #797 of 1,389 in the Bio & Health League; #5706 of 12,443 overall (2024)
- Incorporated
- 2020
- Entity
- Corporation
Form D filings since 2024 5
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-30 | Amendment | $747K | $2.5M | SEC |
| 2026-01-08 | Amendment | $542K | $542K | SEC |
| 2025-10-14 | New notice | $397K | $397K | SEC |
| 2025-02-04 | New notice | $1M | $4M | SEC |
| 2024-03-26 | New notice | $1.9M | $3.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1815624.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Akari Therapeutics Plc | Bio & Health | $2M |
| 2 | Absco Therapeutics, Inc. rookie | Bio & Health | $2M |
| 3 | Mitosense, Inc. | Bio & Health | $1.9M |
| 4 | Ebs Acq, LLC rookie | Bio & Health | $1.8M |
| 5 | StataDx, Inc. | Bio & Health | $1.8M |
| 6 | Microbot Medical Inc. | Bio & Health | $1.8M |